URL has been copied successfully!
Skip to content
JBizNews
JBizNews
Primary Navigation Menu
Menu
  • Home
  • Breaking News
  • Top News
  • Markets
  • Crypto
  • Health
  • Real Estate
  • Events
  • Subscribe
  • About JBizNews

Health

  • May 4, 2026

    What to know about hantavirus, the illness suspected in a cruise ship outbreak


  • May 4, 2026

    How states are planning to implement Medicaid work requirements: survey


  • May 4, 2026

    STAT+: Biotech raises $42 million to run Huntington’s disease trial


  • May 4, 2026

    Preparing for the 2026 HIPAA changes: A practical guide for healthcare leaders


  • May 4, 2026

    What’s next for post-acute care: Data, collaboration and the path forward


  • May 4, 2026

    Opinion: STAT+: China’s strict new supply chain regulations could create massive problems for Western biopharma companies


  • May 4, 2026

    Opinion: Are blue zones real? Answering that question is harder than ever


  • May 4, 2026

    Immigration changes are driving foreign researchers to leave the U.S. — or not come to begin with 


  • May 2, 2026

    Teva Pharmaceuticals Surges To Record Profits, Stock Jumps 12%


  • May 2, 2026

    Federal appeals court blocks mailing of abortion pill mifepristone


  • May 2, 2026

    Opinion: STAT readers on MAHA activists, perimenopause, and diversity in medical school


  • May 2, 2026

    Opinion: What do medical students think about their education?


  • May 1, 2026

    Education Department caps graduate student loans, hitting health workforce


  • May 1, 2026

    Nebraska rolls out Medicaid work requirements, putting tens of thousands at risk of coverage losses


  • May 1, 2026

    Cost management, outpatient unit helped Tenet weather volume headwinds in Q1


  • May 1, 2026

    PFAS is still in some infant formula


  • May 1, 2026

    STAT+: Pharmalittle: We’re reading about obesity drugs and a compounding list, an AstraZeneca setback, and more


  • May 1, 2026

    STAT+: Axsome wins FDA nod for Alzheimer’s agitation


  • May 1, 2026

    Opinion: The psychedelic revolution is leaving behind people of color


  • May 1, 2026

    ‘Forever chemicals’ in baby formula? Scientists unpack FDA results


  • May 1, 2026

    STAT+: Her daughter Mila got a bespoke medicine. Now she’s starting a new biotech to make more


  • May 1, 2026

    Opinion: America is worrying about fertility again. But it’s not really about families


  • April 30, 2026

    STAT+: OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence


  • April 30, 2026

    Remembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstood


  • April 30, 2026

    OSHA Issues New Guidance on Heat Stress Protection for Outdoor and Warehouse Workers as Summer Approaches


  • April 30, 2026

    STAT+: Katherine Szarama named acting director of FDA’s vaccines and biologics center


  • April 30, 2026

    STAT+: In her own words: Surgeon general nominee Nicole Saphier expresses enthusiasm and caution for MAHA


  • April 30, 2026

    STAT+: Hair-raising trial results, and Servier’s M&A wishlist


  • April 30, 2026

    STAT+: FDA wants to exclude weight loss drugs from a compounding list


  • April 30, 2026

    Trump drops Casey Means as surgeon general nominee, opts for radiologist Nicole Saphier


  • April 30, 2026

    STAT+: As artificial intelligence shows off diagnostic chops, scientists reckon with the way forward


  • April 30, 2026

    STAT+: DOJ, Elevance spar over access to top exec in Medicare Advantage fraud case


  • April 30, 2026

    STAT+: Five-way obesity drug is super effective — in mice


  • April 30, 2026

    Cigna exits ACA exchanges despite dramatic profit growth in Q1


  • April 30, 2026

    STAT+: Democrats go hard on health care affordability


  • April 30, 2026

    STAT+: Cigna will exit ACA individual markets next year, adding to tumult for patients


  • April 30, 2026

    STAT+: Hinge has a new FDA-cleared migraine device


  • April 30, 2026

    Surgeries are moving to ASCs. Distalmotion wants its robot to drive the shift.


  • April 30, 2026

    Consumer health data’s regulatory patchwork is growing. Relief isn’t coming.


  • April 30, 2026

    STAT+: Pharmalittle: We’re reading about a Supreme Court hearing on ‘skinny labels,’ AstraZeneca U.K. expansion, and more


Previous Page
1 … 26 27 28 29 30 … 40
Next Page
2026-03-30

JBIZNEWS LLC © 2026